Profil
Edward Kim is currently Chief Medical Officer at Orexo AB since 2022.
Formerly, Dr. Kim was Vice President & Head-Medical Affairs at Biohaven Pharmaceutical Holding Co. Ltd. from 2020 to 2022 and Vice Chairman-Clinical Services at Robert Wood Johnson Medical School.
Education includes an undergraduate degree from Harvard University, a doctorate from Sidney Kimmel Medical College, and an MBA from the University of Massachusetts.
Aktive Positionen von Edward Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| OREXO AB | Technik-/Wissenschafts-/F&E-Leiter | 26.10.2022 |
Ehemalige bekannte Positionen von Edward Kim
| Unternehmen | Position | Ende |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01.10.2022 |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Edward Kim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
















